Boxer Capital, LLC
CIK 1465837 · last filed 2023-10-11
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$422.24M
Companies
8
Total Filings
27
Lifetime Open-Market Net
$238.19M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| TNGX | 13,937,092 | $27.97 | $389.82M | -$11.20M | 1 | 2023-10-11 | |
| RAIN | Director | 1,152,212 | $2.06 | $2.37M | $54.57M | 2 | 2023-05-24 |
| Odonate Therapeutics, Inc. (ODT) Delisted | Director | 4,207,086 | $1.12 | $4.71M | $133.68M | 8 | 2021-11-24 |
| PMVP | 982,708 | $1.13 | $1.11M | $85.50M | 1 | 2020-09-29 | |
| iTeos Therapeutics, Inc. (ITOS) Delisted | 10%+ Owner | 2,943,568 | $10.15 | $29.88M | $108.30M | 1 | 2020-07-29 |
| Mirati Therapeutics, Inc. (MRTX) Delisted | 10%+ Owner | 1,765,560 | $58.70 | $103.64M | -$122.81M | 8 | 2020-01-14 |
| SLDB | 10%+ Owner | 3,473,272 | $8.33 | $28.93M | -$4.45M | 1 | 2019-03-28 |
| Pernix Sleep, Inc. (SOMX) Delisted | 876,489 | — | — | -$5.40M | 2 | 2009-08-28 |
Recent Filings · Page 3 of 3
27 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-10-26 | Odonate Therapeutics, Inc. (ODT) Delisted | Buy (P) | +80,472 | $1.18M | EDGAR |
| 2017-12-08 | Odonate Therapeutics, Inc. (ODT) Delisted | Buy (P) | +1,249,998 | $30.00M | EDGAR |
| 2017-10-03 | Mirati Therapeutics, Inc. (MRTX) Delisted | Exer (X) | +535,932 | $4.21M | EDGAR |
| 2016-03-17 | Mirati Therapeutics, Inc. (MRTX) Delisted | Other (J) | −474,158 | $0 | EDGAR |
| 2016-01-15 | Mirati Therapeutics, Inc. (MRTX) Delisted | Other (J) | −791,139 | $0 | EDGAR |
| 2009-08-28 | Pernix Sleep, Inc. (SOMX) Delisted | Sell (S) | −285,000 | -$752.4K | EDGAR |
| 2009-07-29 | Pernix Sleep, Inc. (SOMX) Delisted | Sell (S) | −1,500,000 | -$4.65M | EDGAR |
Showing 21–27 of 27
Prev
Page 3 of 3
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.